A retrospective study at Northwestern University Feinberg School of Medicine, Chicago, showed that dialysis patients who ...

Catheters of all types as well as other intravascular devices (IVDs) that allow access to the bloodstream are potential ...

ATS Medical, Inc., a manufacturer of cardiac surgery products and services focused, has announced completion of its ...

FDA and Duke Clinical Research Institute will be working to develop a new generation of tools that enable early identification of potential cardiac side effects of drugs and devices. The agency will use a database comprising more than 200,000 ECGs to conduct the research.

Researchers in The Netherlands say they’ve realized the dream of truly interactive 3-D medical imaging: A company called Crosslinks is working to develop and market a software invention in Europe and around the world that provides 3-D visualization that clinicians and researchers can not only view head-on, but actually walk around and through.

Administering a cholesterol-lowering drug prior to heart bypass surgery or surgical repair of a faulty heart valve may reduce the occurrence of atrial fibrillation, a common heart rhythm disturbance triggered by these surgeries. The research was published in “Circulation: Journal of the American Heart Association.”

Zargis Medical Corp., a spin-off from Siemens Corporate Research and a majority-owned subsidiary of Speedus Corp., has ...